Starboard to Vote Against Bristol-Celgene Deal, Suggests a Sale Instead

(Bloomberg) -- Activist investor Starboard Value said it will vote against the record pharmaceutical merger of Bristol-Myers Squibb Co. and Celgene Corp., launching a shareholder campaign that coul...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.